Calendar Companies Compare Analytics Learn Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar tracking FDA decisions, clinical trial results, and PDUFA dates for biotech stocks.

Quick Links

Catalyst Calendar
Search Companies
Biotech Glossary
Therapeutic Areas

Legal

About
Privacy
Terms

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

© 2025 CatalystAlert. All rights reserved.

Not financial advice. Data may be delayed or incomplete.

TNG260 - Phase 2 | TNGX Pipeline | CatalystAlert

TNG260

Phase 2

Tango Therapeutics, Inc. (TNGX)

15%

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts

Jan 2026~

TNGXPhase 2Phase 2

TNG260 Phase 2 Results Expected

TNG260 • Non Small Cell Lung Cancer

Drug Information

Target Indication

Non Small Cell Lung Cancer

Clinical Trial

Last updated: 12/4/2025

Developer

TNGX

Tango Therapeutics, Inc.

Biotechnology•North America•NASDAQ